NL-OMON45060已完成不适用
Post-operative RadioTherapy for patients with metastases of the long bones - OPTIMAL-PORT Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Aged 18 or older
- •- Receive surgical treatment (prosthesis, intramedullary nail, plate, curettage with/without cement) with palliative intent for a pathologic fracture or impending pathologic fracture of the extremities (humerus/femur and further distal) due to metastatic bone disease
- •- Radiographic or histologic proof of metastatic bone disease
- •- Histologic diagnosis of the primary tumour or * if the diagnosis is unknown - at least adequate diagnostic investigations into the origin of the metastasis (e.g. dissemination imaging, histology, biopsy)
排除标准
- •- Communication with patient is hampered (e.g. language barrier, severe cognitive impairment, dementia)
- •- The treated lesion originates from multiple myeloma, solitary plasmacytoma or lymphoma of bone
- •- Further radiotherapy is considered inappropriate (> 2 series RT on current lesion)
- •- Physically unable to undergo post-operative RT treatment, according to treating doctor*s opinion
- •- Absolute need for post-operative treatment with radiotherapy, specify reason:
- •o Extent of bone lesion (outside surgical field)
- •o Soft tissue involvement
- •o Curative intent of treatment
研究者
相似试验
招募中
3 期
Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial (JCOG1916, J-PORT)pathological N2 non-small cell lung cancerJPRN-UMIN000042905Japan Clinical Oncology Group (JCOG)330
已完成
4 期
Effectiveness of postoperative radiotherapy in patients with oral or oropharyngeal squamous cell carcinoma and histologically confirmed single ipsilateral lymphnode metastasis (pN1)head-neck cancer metastasis1002747610019190oral cancerNL-OMON30589Academisch Medisch Centrum12
进行中（未招募）
1 期
Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus post-operative external radiotherapy alone in pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10 prostatic carcinoma. A Phase III studyEUCTR2006-002772-17-FREuropean Organisation for Research and Treatment of Cancer86
已完成
不适用
Post-Operative Radiotherapy for Selected High Risk Rectal AdenocarcinomaColorectal cancerColorectalCancerISRCTN91411631orthern and Yorkshire Clinical Trials and Research Unit (UK)
进行中（未招募）
不适用
Radioterapia externa postoperatoria combinada con tratamiento hormonal adyuvante y concomitante frente a la radioterapia externa postoperatoria como tratamiento único en el carcinoma de próstata estadio pT3a-b R0-1 N0M0 / pT2R1 N0M0 y con puntuación de Gleason 5-10. Estudio fase III.(Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus post-operative external radiotherapy alone in pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10 prostatic carcinoma. A Phase III study)n carcinoma de próstata estadio pT3a-b R0-1 N0M0 / pT2R1 N0M0 y con puntuación de Gleason 5-10.(Prostatic carcinoma with pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10)MedDRA version: 9.1Level: LLTClassification code 10036955Term: Prostatic carcinomaEUCTR2006-002772-17-ESEuropean Organisation for Research and Treatment of Cancer600